• Carl Zeiss Meditech (Dublin, California) reported that a new suite of optical coherence tomography (OCT) software applications for the Cirrus HD-OCT has been cleared by the FDA for commercial distribution. The Cirrus HD-OCT 4.0 with Retinal Nerve Fiber Layer and Macular Normative Databases is indicated for in-vivo viewing, axial cross-sectional, and three-dimensional imaging and measurement of anterior and posterior ocular structures. Cirrus-HD OCT software version 4.0 is DICOM compatible for use with Carl Zeiss Meditec's connectivity solutions, including VISUPAC Star and EMR platforms.

• Clinical Innovations (Salt Lake City) has launched its new disposable circumcision device, the AccuCirc, to help clinicians provide precise, consistent and reliable circumcision outcomes. The AccuCirc uses two components to complete the circumcision procedure: the foreskin probe/shielding ring and the single-action clamp. The Foreskin Probe/Shielding Ring ensures that the glans is protected and the foreskin is properly aligned, while the single-action clamp ensures adequate hemostasis and the precise delivery of the protected, circular blade.

• DxNA (St. George, Utah) said it has submitted a request to the FDA for Emergency Use Authorization (EUA) for its GeneSTAT pathogen platform, for the detection of the H1N1 virus (known as swine flu). EUA allows for the early availability of important diagnostic and therapeutics tools to diagnose, treat, or prevent critical or life-threatening diseases or conditions, when an alternative or approved solution is not available. The GeneSTAT platform includes a portable device that offers remote usage to rapidly detect pathogens where outbreaks are suspected. The device can be used in gateway airports, at local health departments and schools, where on-site rapid and non-invasive screening for highly contagious pathogens is advised. The GeneSTAT test module requires a simple swab of the mouth, nose or throat. The company is developing a number of follow-on tests to detect pathogens that may affect people and agriculture.

• Filligent (Hong Kong) is mobilizing stocks of its anti-infective BioMask to help combat the spread of Influenza A (H1N1) across Australia. Filligent claims that the BioMask is the first medical face mask to kill the Influenza A virus within seconds of contact while retaining the breathability required by front-line workers and children, who are often the first to fall in a contagious episode. The BioMask is a Class I medical face mask that traps and kills 99.9% of bacteria and viruses on contact.

• MedApps (Scottsdale, Arizona) has been granted FDA clearance for its expanded, flexible telehealth solution. The MedApps system features the HealthPAL, a small portable personal health device, to collect and transmit readings from glucose meters, blood pressure monitors, weight scales and pulse oximeters. Timely health readings from these devices are useful in maintaining wellness regimens and can assist clinicians in their treatment of patients with chronic diseases. The collected data is automatically transmitted to a secure central server where it can be accessed by healthcare professionals or stored to an online electronic personal health record such as Microsoft HealthVault or Google Health.

The Musculoskeletal Transplant Foundation (MTF; Edison, New Jersey) has introduced BellaDerm — the first human dermal tissue graft offered specifically for facial and body contouring procedures. BellaDerm is a acellular matrix, derived from donated human allograft skin. BellaDerm provides supplemental support in areas of weakness. It has been used by plastic surgeons to address naturally occurring defects which may be found in areas such as the breast, lips, and face.

• Nonin Medical (Minneapolis) said its Bluetooth-enabled fingertip pulse oximeter, Onyx II, Model 9560 is now certified as compliant to the Continua Version One Design Guidelines. Nonin said by using the Bluetooth Health Device Profile (HDP) and ISO/IEEE 11073 data protocol, this Continua Certified product signifies a major step in the adoption of interoperable standards in telemedicine and chronic disease management such as COPD, CHF and asthma. Nonin specializes in noninvasive physiological monitoring solutions.